In summary, triggering ferroptosis is an effective therapeutic strategy for TNBC
doi: 10.1186/1471-2261-14-88
In a 2017 study using human vascular endothelial cells and a chick chorioallantoic membrane assay, Hsieh and colleagues reported that BPC-157 exposure increased VEGFR2 mRNA and protein expression, promoted VEGFR2 internalization (an effect blocked by the endocytosis inhibitor dynasore), and time-dependently activated the VEGFR2-Akt-eNOS axis without a corresponding increase in VEGF-A (Hsieh et al., 2017)
M., Yan, J
Specifically, under Gln+ conditions, highly active c-Myc represses miR-29b-3p transcription, leading to a substantial reduction in its expression
I'm Jill Brook, and this is Mast Cell Matters, where we go deep on all things related to Mast Cell Activation Syndrome or MCAS, with the help of our wonderful guest host, Dr